Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Observational × Urine Specimen Collection × Clear all

Status

Unknown 4 Completed 4 Recruiting 3 Terminated 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Blood Specimen Collection 17 Surveys and Questionnaires 13 Therapeutics 6 Psychiatric Rehabilitation 6 Polymerase Chain Reaction 5 Interviews as Topic 5 Immunohistochemistry 5 Gene Expression Profiling 5 Biopsy 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 High-Energy Shock Waves 4 Reverse Transcriptase Polymerase Chain Reaction 3 Microarray Analysis 3 Fluorodeoxyglucose F18 3 Abiraterone Acetate 3 Watchful Waiting 2 Standard of Care 2 Specimen Handling 2 Prednisone 2 Methods 2 Leuprolide 2 In Situ Hybridization, Fluorescence 2 Hematologic Tests 2 Glucose Tolerance Test 2 Comparative Genomic Hybridization 2 Biopsy, Fine-Needle 2 Bariatric Surgery 2 Azacitidine 2 Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04268693 2022-11-17

EDC-TNBC

George Washington University

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡